Arbutus Biopharma Corp. (ABUS)
4.66
+0.07
(+1.53%)
USD |
NASDAQ |
Dec 11, 16:00
4.66
0.00 (0.00%)
After-Hours: 18:30
Arbutus Biopharma Total Assets (Quarterly): 97.71M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 42.71B |
| Trevi Therapeutics, Inc. | 199.36M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.31M |
| Shareholders Equity (Quarterly) | 77.40M |
| Debt to Equity Ratio | 0.0595 |
| Current Ratio | 18.80 |
| Net Debt Paydown Yield | 0.07% |